同一日,君实生物、诺诚健华、一品红等多家药企发布利好消息

制药网
Dec 15, 2025

12月14日,君实生物、诺诚健华、一品红等多家医药企业发布利好消息。这些成果不仅彰显了医药行业企业的创新实力,更印证了我国医药产业在政策护航下高质量发展的强劲势头。其中,君实生物12月14日发布公告称,公司收到美国食品药品监督管理局(FDA)的通知,EGFR/HER3双特异性抗体偶联药物(代号:JS212)用于治疗晚期实体瘤的临床试验申请获得FDA批准。JS212主要用于晚期恶性实体瘤的治疗,与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10